Forgent Power Solutions, Inc. Class A Common Stock (FPS)

This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.

Forgent Power Solutions (NYSE:FPS) reported record fiscal third-quarter results and raised its full-year outlook, citing stronger-than-expected demand from data center and grid customers, expanding backlog and early signs of operating leverage as it scales production. Chief Executive Officer Gary N

Forgent Power Solutions, Inc. (NYSE: FPS) shares are trading higher Monday after the company reported second-quarter financial results.